Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.30 |
| ▸ | AKT2 | P31751 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL239179 | 0.87 | ESR1 (0.48) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL11023990 | 0.81 | ESR1 (0.44) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL23532344 | 0.81 | ESR1 (0.44) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL10150936 | 0.79 | ESR1 (0.42) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL244122 | 0.79 | ESR1 (0.42) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL10616290 | 0.77 | ESR1 (0.41) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL8939087 | 0.77 | ESR1 (0.41) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL8214590 | 0.77 | ESR1 (0.41) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL10355215 | 0.77 | ESR1 (0.41) | ESR1ESR2NR1H2NR1H3TSHR | |
| SCHEMBL9757676 | 0.77 | ESR1 (0.46) | ESR1ESR2NR1H2NR1H3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230253626-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-08-10 | — | — | US | disclosed |
| US-11688881-B2 | Nonaqueous electrolytic solution and nonaqueous electrolytic solution secondary battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| US-11688881-B2 | Nonaqueous electrolytic solution and nonaqueous electrolytic solution secondary battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| US-20200144670-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-05-07 | — | — | US | disclosed |
| US-20180019499-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2018-01-18 | — | — | US | disclosed |
| US-9806375-B2 | Nonaqueous electrolytic solution and nonaqueous electrolytic solution secondary battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20170018805-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-01-19 | — | — | US | disclosed |
| US-20170018805-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-01-19 | — | — | US | disclosed |
| US-20150080596-A1 | Method Of Reducing A Halosilane Compound In A Micoreactor | DOW CORNING CORPORATION | 2015-03-19 | — | — | US | disclosed |
| US-20140363735-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20140363735-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20130309564-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-11-21 | — | — | US | disclosed |
| US-7169697-B2 | Semiconductor device and manufacturing method of the same | KABUSHIKI KAISHA TOSHIBA (JP) | 2007-01-30 | — | — | US | disclosed |
| EP-0325248-B1 | A process for the chlorodephenylation of phenylsilanes | DOW CORNING (US) | 1994-06-15 | — | — | EP | disclosed |
| US-5068381-A | Reaction of silane with acetylene compound for use as a crosslinking agent and as a photosensitive agent | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1991-11-26 | — | — | US | disclosed |
| US-4855471-A | Process for the chlorodephenylation of phenyldisilanes | DOW CORNING CORPORATION (US) | 1989-08-08 | — | — | US | disclosed |
| EP-0325248-A2 | A process for the chlorodephenylation of phenylsilanes | DOW CORNING CORPORATION (US) | 1989-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080596-A1 | Method Of Reducing A Halosilane Compound In A Micoreactor | MSN, MGMT, BHMT2 | ESR1 4824/4885ESR2 4758/4885NR1H2 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.